Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines 2016

P Kapoor, SM Ansell, R Fonseca… - JAMA …, 2017 - jamanetwork.com
Importance Waldenström macroglobulinemia (WM), an IgM-associated lymphoplasmacytic
lymphoma, has witnessed several practice-altering advances in recent years. With …

Waldenström macroglobulinemia: What a hematologist needs to know

P Kapoor, J Paludo, N Vallumsetla, PR Greipp - Blood Reviews, 2015 - Elsevier
Waldenström macroglobulinemia (WM) is a distinct hematologic malignancy characterized
by a lymphoplasmacytic bone marrow infiltration and the presence of immunoglobulin (Ig) M …

Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience

KL Chohan, J Paludo, N Vallumsetla… - American journal of …, 2023 - Wiley Online Library
Waldenström macroglobulinemia (WM) is a rare, indolent lymphoma, that predominately
affects the elderly. We report the outcomes of young WM patients, evaluated over five …

Waldenström Macroglobulinemia-A State-of-the-Art Review: Part 1: Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, risk …

M Bibas, S Sarosiek, JJ Castillo - Mediterranean Journal of …, 2024 - pmc.ncbi.nlm.nih.gov
Waldenström macroglobulinemia (WM) is an infrequent variant of lymphoma, classified as a
B-cell malignancy identified by the presence of IgM paraprotein, infiltration of clonal, small …

Allogeneic transplantation for relapsed Waldenström macroglobulinemia and lymphoplasmacytic lymphoma

RF Cornell, V Bachanova, A D'Souza… - Biology of Blood and …, 2017 - Elsevier
Waldenström macroglobulinemia/lymphoplasmacytic lymphoma (WM/LPL) is characterized
by lymphoplasmacytic proliferation, lymph node and spleen enlargement, bone marrow …

Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemia

MDSK Gunaratne, AJ Sahakian… - Leukemia & …, 2021 - Taylor & Francis
Waldenstrom macroglobulinemia (WM) has an annual incidence of 3–3.2 cases per million-
person/year. National Cancer Data Base was used to identify newly diagnosed WM cases …

Waldenstrom macroglobulinemia: genomic aberrations and treatment

P Kapoor, SM Ansell, E Braggio - Plasma Cell Dyscrasias, 2016 - Springer
Waldenström macroglobulinemia (WM) is a rare, indolent, and monoclonal immunoglobulin
M-associated lymphoplasmacytic disorder with unique clinicopathologic characteristics …

Lung consolidation as a rare presentation of lymphoplasmacytic lymphoma with extramedullary Waldenström's macroglobulinemia

O Abdulfattah, EU Rahman, B Bhattarai… - Journal of Community …, 2018 - Taylor & Francis
Objectives: Lymphoplasmacytic lymphoma (LPL) is a mature B cell lymphoma that usually
involves the bone marrow, spleen and lymph nodes. Extramedullary involvement, including …

Why Waldenström macroglobulinemia is not just another indolent lymphoma

RF Cornell, LJ Burns, V Bachanova - International Journal of …, 2014 - Taylor & Francis
Waldenström macroglobulinemia (WM) is an uncommon B-cell malignancy arising from B
cells that are arrested after somatic hypermutation in the germinal center and before terminal …

[PDF][PDF] Újdonságok a Waldenström-makroglobulinémia kezelésében

MO ANNA, N ZSOLT - Magyar onkologia, 2017 - huon.hu
BEVEZETÉS A Waldenström-makroglobulinémia (WM) az indolens non-Hodgkin-limfómák
csoportjába tartozó limfoplazmocitás limfóma, ahol a malignus, IgM immunglobulint …